Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Fragments of e-Cadherin as Biomarkers of Non-erosive Reflux Disease

Fragments of e-Cadherin as Biomarkers of Non-erosive Reflux Disease Dig Dis Sci (2018) 63:628–635 https://doi.org/10.1007/s10620-017-4815-4 ORIGINAL ARTICLE Fragments of e-Cadherin as Biomarkers of Non-erosive Reflux Disease 1,3 1,2 1,5 1,8 • • • • Biljana Jovov Craig C. Reed Nicholas J. Shaheen Amy Pruitt 1,6 1,7 1,4 1,7 • • • Kathleen Ferrell Geraldine S. Orlando Zorka Djukic Roy C. Orlando Received: 26 August 2017 / Accepted: 17 October 2017 / Published online: 25 October 2017 Springer Science+Business Media, LLC 2017 Abstract received dexlansoprazole 30 mg daily for 4 weeks, and Background Approximately, 20% of patients with heart- heartburn was assessed by daily diary entry. Post-treatment burn and normal endoscopic findings do not symptomati- blood samples were obtained for serum NTFs. A control cally improve on proton pump inhibitor (PPI) therapy group without GERD symptoms (n = 6) had biopsies for making diagnosis and treatment uncertain. A biomarker CTFs and a second control group (n = 20) blood serum for distinguishing PPI-responsive from PPI-refractory heart- serum NTFs. burn is desirable. Results Twenty-seven of 29 patients (93.1%) with endo- Aims We performed a pilot study assessing whether car- scopy-negative heartburn, but 0 of 6 controls, were positive boxy(C)-terminal fragments (CTFs) of e-cadherin in eso- for CTFs. All patients and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Digestive Diseases and Sciences Springer Journals

Loading next page...
1
 
/lp/springer_journal/fragments-of-e-cadherin-as-biomarkers-of-non-erosive-reflux-disease-mLLbFoDexO

References (19)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Gastroenterology; Hepatology; Oncology; Transplant Surgery; Biochemistry, general
ISSN
0163-2116
eISSN
1573-2568
DOI
10.1007/s10620-017-4815-4
pmid
29071486
Publisher site
See Article on Publisher Site

Abstract

Dig Dis Sci (2018) 63:628–635 https://doi.org/10.1007/s10620-017-4815-4 ORIGINAL ARTICLE Fragments of e-Cadherin as Biomarkers of Non-erosive Reflux Disease 1,3 1,2 1,5 1,8 • • • • Biljana Jovov Craig C. Reed Nicholas J. Shaheen Amy Pruitt 1,6 1,7 1,4 1,7 • • • Kathleen Ferrell Geraldine S. Orlando Zorka Djukic Roy C. Orlando Received: 26 August 2017 / Accepted: 17 October 2017 / Published online: 25 October 2017 Springer Science+Business Media, LLC 2017 Abstract received dexlansoprazole 30 mg daily for 4 weeks, and Background Approximately, 20% of patients with heart- heartburn was assessed by daily diary entry. Post-treatment burn and normal endoscopic findings do not symptomati- blood samples were obtained for serum NTFs. A control cally improve on proton pump inhibitor (PPI) therapy group without GERD symptoms (n = 6) had biopsies for making diagnosis and treatment uncertain. A biomarker CTFs and a second control group (n = 20) blood serum for distinguishing PPI-responsive from PPI-refractory heart- serum NTFs. burn is desirable. Results Twenty-seven of 29 patients (93.1%) with endo- Aims We performed a pilot study assessing whether car- scopy-negative heartburn, but 0 of 6 controls, were positive boxy(C)-terminal fragments (CTFs) of e-cadherin in eso- for CTFs. All patients and

Journal

Digestive Diseases and SciencesSpringer Journals

Published: Oct 25, 2017

There are no references for this article.